retatrutide weight loss retatrutide clinical trial (“reta”) is an experimental weight-loss drug currently in Phase 3 trials. It's a once-weekly injection similar to Ozempic and Mounjaro—but more powerful. The reason comes down to how it works VisualAbstract: Retatrutide reduces body weight
Description
*Compounded drugs are permitted to be prescribed under federal law but are not FDA-approved and do not undergo FDA review for safety, effectiveness, or quality.
What does my anesthesia plan need to account for
The clinical evidence base for these two compounds differs substantially in maturity, scope, and regulatory recognition
For individuals, moving from a systolic reading of 138 to 131 moves them from the Stage 1 hypertension category toward the high-normal range, a meaningful clinical milestone even before factoring in weight change
J Neurosurg, 44:337-341
Swelling can also be reduced with minimally invasive steps
